Lifecare

Successfully completed nine weeks of longevity trials! The Sencell sensor that has been implanted under the skin of the dog Elli has now passed an operational lifetime of two months and still counting. During these months, the Lifecare Veterinary team located at the NMBU - Norwegian University of Life Sciences has received large amounts of data. This validates the functionality of the Sencell sensor and the sensor technology itself. The results from the study, which has been ongoing throughout the summer, is in line with what we expected. However, it is very encouraging to achieve the positive results of longevity in real-world settings. As we have passed two months of operational lifetime, based on a wireless readout, we are proud to conclude that the initial part of the longevity study is a success. 👨🔬 Previous in-vitro studies have confirmed sensor lifetime of six months. ⏳ With this initial conclusion of more than 9 weeks operational lifetime in vivo – in real life settings – we exceed the operational lifetime of all the major CGM systems in the market with a factor of 4,5 or more. This is, of course, interesting in a future commercial perspective 🐕 The main purpose of the first sensor of the longevity trial is to investigate and confirm operational lifetime in a longevity perspective. ❤️ The Team at Lifecare Veterinary monitors the first pet-patient Elli on a daily basis, including reports from her owner. Elli is in good health and shows no signs of discomfort related to the implant. Alongside the initial part of the longevity study, we are preparing to enroll additional patients in the study to confirm these first results, and to intensify the study beyond sensor functionality, focusing sharper on glucose readings from both healthy dogs and dogs with diabetes. With this approach we expect to gain increased understanding of the sensor functionality in real life conditions. #diabetes #veterinary #medtech #cgm #sensortechnology #hundehelse Joacim Holter Prof. Dr. Dr. med. Andreas Pfützner Renete Kaarvik Jo Oeding Amundstad Sivert Nerhagen Kristin Anfinsen Tuva Onarheim Asle Steiestøl Wingsternes Julie Lundekvam Barbora Tencer Ahmad Fazli Torsten Ernst Aslak Fisketjønn Lenitha Schwartz Nicole Thomé Jordan Gardiner Dr. Preeti SHARMA Mandar Mehta Vrushali Godse Hendrick Jensch Christoph Füger Dr. Jeanette Hütges MedWatch Norge: https://lnkd.in/dj7xbpJt Lifecare web: https://lnkd.in/dBKdJYUC

We are pleased to announce a strategic cooperation with OneTwo Analytics AB (OneTwo), a Swedish-based company specializing in data analytics of diabetes data. The strategic cooperation will provide Lifecare access to OneTwo Analytics' portfolio of comprehensive AI and ML based software for self-monitoring and automatic interpretation of CGM data. Furthermore, OneTwo will act as Lifecare’s digital development partner on a consultancy base, as Lifecare intends to commercialize the software tool in the field of veterinary medicine on a license-base. ✅ This marks a significant milestone in the advancement of veterinary medicine, aiming to bring cutting-edge analytical software developed for the human diabetes market to the veterinary field. 👩⚕️ OneTwo will leverage its expertise in data analytics and software development to create a digital infrastructure tailored to the needs of veterinary professionals. 📲 As part of the strategic cooperation, OneTwo will also develop a user-friendly mobile application compatible with both iOS and Android platforms. This app will facilitate seamless data transmission from the Sencell sensors to cloud servers and enable bi-directional communication with the customized analytical software. The digital infrastructure will not only serve the veterinary sector but also retain compatibility for potential human healthcare applications. 📈 We will take the lead in commercializing this advanced analytical software within the global veterinary market. The partnership grants us an exclusive, worldwide license to modify, market, and brand the software under its name. This software is designed to analyze glucose data from CGM sensors, providing critical insights into glucose deviations and fluctuations, which are vital for the diagnosis, treatment, and management of diabetes. – Lifecare’s vision has always been to make glucose monitoring easier for the patient using our Sencell sensor. In order to meet that customer promise, we must also be able to easily provide insight into valuable diabetes data through innovative and user-friendly software solutions, says Joacim Holter, CEO of Lifecare. READ MORE: https://lnkd.in/d_Zv7cbj #cgm #diabetes #medtech #sensortechnology #dataanalytic #glucoseapp Morten Foros Krohnstad Trine Teigland Lutz, Prof. Dr. Heinemann Hans Hekland Tone Kvåle Prof. Dr. Dr. med. Andreas Pfützner Renete Kaarvik Jo Oeding Amundstad Asle Steiestøl Wingsternes Julie Lundekvam Aslak Fisketjønn Ahmad Fazli Barbora Tencer Nicole Thomé Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Christoph Füger Mandar Mehta Vrushali Godse Nicole Neil Lenitha Schwartz. Torsten Ernst Marte Bratlie Sivert Nerhagen Tuva Onarheim OneTwo Analytics AB: Lars Cederblad

The first implant in our longevity trial has survived for four weeks - and the study continues! Morten Foros Krohnstad Trine Teigland Lutz, Prof. Dr. Heinemann Hans Hekland Tone Kvåle Joacim Holter Prof. Dr. Dr. med. Andreas Pfützner Renete Kaarvik Jo Oeding Amundstad Asle Steiestøl Wingsternes Julie Lundekvam Aslak Fisketjønn Ahmad Fazli Barbora Tencer Nicole Thomé Jordan Gardiner Dr. Preeti SHARMA. Christoph Füger Mandar Mehta Vrushali Godse Nicole Neil Lenitha Schwartz. Dr. Jeanette Hütges Torsten Ernst Kristin Anfinsen. Marte Bratlie Sivert Nerhagen Tuva Onarheim

Yesterday afternoon, Lifecare presented at the International MARSS Conference on Manipulation Automation and Robotics at Small Scale in Delft, Netherlands. The talk entitled „Autodeposition of Nanosensors for Glucose Monitoring Application“ was given by our lead bioinformatics scientist Rustam Giliaziev and was very well received by the attending audience. The presentation described the automation process for the NTR-Sensor deposition on the pressure membrane of our glucose sensor that was developed by our Nanobiosensor expert team: Dr. Boris Stamm, Dr. Preeti SHARMA, Christoph Füger, Rustam Giliaziev, Vrushali Godse At Lifecare Nanobiosensors in Reutlingen, Germany. This process is a key step forward to our automated Sencell manufacturing process and will help to increase the quality and accuracy of the sensor product, as it eliminates the risk of human errors in the sophisticated Deposition process by FEBID (fast electrone beam induced deposition). Well done! Joacim Holter , Morten Foros Krohnstad , Ahmad Fazli , Hans Hekland , Trine Teigland , Tone Kvåle , Lutz, Prof. Dr. Heinemann , Lifecare , Asle Steiestøl Wingsternes , Barbora Tencer , Nicole Thomé , Ahmad Fazli , Torsten Ernst

I have spent three days at the 2024 American Diabetes Association Scientific Sessions in Orlando. Exciting and valuable for me and for Lifecare, browsing through loads of information in scientific sessions as well as industry sessions. I took the opportunity to update the chairman of Lifecare’s Scientific Advisory Board, Professor David Klonoff on the status of our longevity studies and preparations for the veterinary market. Among the industry news disclosed in relation to the #ADA2024 I notice that Abbott have increased the longevity of their #CGM from 14 days to 15 days 🤔, and that both Abbott and Dexcom now have FDA approval for Over The Counter versjons of their CGM’s. This is market relevant developments, however for me the most interesting news came from Senseonics, Incorporated disclosing that they not only have applied for a 365 day clearance for their CGM, but also disclosed that they are working on battery and Low Energy Bluetooth to enable a CGM without a unit on the skin. Way to go Senseonics 👏🏻, paving the way for the next generation of CGM”s! The developments are inspiring for Lifecare, as we now look forward to shortly report the first conclusions and finding from our longevity study. Morten Foros Krohnstad Trine Teigland Lutz, Prof. Dr. Heinemann Hans Hekland Tone Kvåle Prof. Dr. Dr. med. Andreas Pfützner Renete Kaarvik Asle Steiestøl Wingsternes Jo Oeding Amundstad Julie Lundekvam Aslak Fisketjønn Barbora Tencer Ahmad Fazli Marte Bratlie Jordan Gardiner Nicole Thomé Dr. Preeti SHARMA Mandar Mehta Anastasios Manessis, MD Niels Ejskjaer i

Jobbdag jeg har sett frem til! I dag var første pasient klar på operasjonssalen, og med det startet vi i Lifecare levetidsdtudien av glukosesensoren vår på hunder. Jeg er takknemlig for muligheten til å lede studien som blir utført på ved NMBU - Norwegian University of Life Sciences. Sammen med meg har jeg noen av de ledende ekspertene innen indremedisin ved universitetet. 🔬 I forrige uke gjennomførte Lifecare Laboratory i Mainz en in vitro-kvalitetstest av den trådløse kommunikasjonen mellom sensoren og en avlesningsenhet. Rapporter har konkludert med at utlesningssignalene oppfyller nødvendige krav fra et produktutviklingsperspektiv. 🚀 Vi kunne derfor sparke i gang studien i dag takket være en solid innsats fra våre team i Reutlingen og Mainz som har utviklet, forbedret, kvalitetssikret og testet sensoren i forkant. Det svært kompetente teamet ved NMBU (Sivert Nerhagen, Tuva Onarheim, Kristin Anfinsen) har vært avgjørende for de nødvendige forberedelsene og prosedyrene for dagens oppstart. ⭐ Det er veldig inspirerende å se kollegaer så tydelig viser høy grad av yrkesstolthet og lidenskap i jobben for å lykkes og nå et felles mål. 🎯 Vårt mål er tydelig: Vi ønsker å hjelpe kjæledyr med diabetes og leve et sunnere og bedre liv. Jeg ser frem til fortsettelsen 😊 Joacim Holter | Prof. Dr. Dr. med. Andreas Pfützner | Vrushali Godse | Ahmad Fazli | Nicole Thomé | Jordan Gardiner | Torsten Ernst | Tony James | Barbora Tencer | Mandar Mehta | Dr. Jeanette Hütges | Lea Weingärtner | Christian Kuhl | Christoph Füger | Julie Lundekvam | Aslak Fisketjønn | Asle Steiestøl Wingsternes #veterinary #medtech #diabetes #animaldiabetes #sensortechnology

Lifecare har hentet inn frisk kapital gjennom en fortrinnsrettet emisjon. - Resulterte i en overtegning på 40 prosent, sier Lifecare-direktør Joacim Holter.

The Norwegian government ha stated the ambition to increase healthcare as an export industry. Today, DNB, Bergen Næringsråd and Eitri hosted a seminar on how Bergen can play a role in this export ambition. With more than 200 participants the turn-out was great! On behalf of Lifecare I participated in a panel discussing how to attract investors to facilitate the export ambition alongside public schemes and support. My main message was to ensure focus and support for #scaleup and #industrialization, in addition to #startups. In addition I emphasized that health is a #global topic, it is important to bring ideas to reality in the world, not only in Bergen. Thanks to DNB, Bergen Chamber of Commerce and Eitri for a great seminar! Sveinung Sleire Torgrim Isaksen, MD Veronica Lundstadsveen Brynjulf Egeland Sverre Simen Hov Ådne Iden Høiland Hanna Braut Marthe Reinkind Håkon Pettersen Magnus Vollset Jeremy McCrohan Thomas Lie Omdahl Hilde Ulvik Hordnes Gerd Kvale Arne Bergby Øyvind Grimsgaard William V. Bettina Husebø S. Mariell Gjerløw Sæternes Gard Madsen Tor Instanes Dagfinn T Hallseth Asle Steiestøl Wingsternes Renete Kaarvik

I’m proud to announce two new hirings in Lifecare as Marte Bratlie has started in the position as Medical Director and Julie Lundekvam has started in the position as Head of People & Culture. Marte Bratlie is a Medical Doctor with a MbChB in Medicine and Surgery from the University of Liverpool, as well as being the founder of RemovAid AS, a company Lifecare recently invested in and became the majority owner of with 81% of the shares. Marthe’s specific background as an MD with experience bringing an idea from the initial stage of innovation into a CE approved medical device is highly relevant and valuable for Lifecare. As Medical Director in Lifecare, Marte will be coordinating product improvements and new product developments and take part in planning and execution of upcoming trials. Marte will also take part the development of the overall strategic direction, particularly in areas related to medical and clinical affairs and contribute to medical communication. Julie Lundekvam holds a Bachelor’s degree in Pedagogy and a Master’s degree in Organizational Psychology from the University of Bergen. Alongside her master’s studies, Julie has up to now worked full-time in Lifecare as an Administrative Coordinator. Alongside her formal education, Julie has practical experience as an important contributor when Lifecare over the recent years have developed into an organization with 5 subsidiaries and close to 40 employees in 3 countries. As Lifecare’s Head of People and Culture, Julie will oversee the fostering of positive workplace culture, facilitating leadership development and promoting a collaborative work environment in the Lifecare Group.  I am very happy to welcome Marte to Lifecare and Julie to a new position in Lifecare! Morten Foros Krohnstad Trine Teigland Lutz, Prof. Dr. Heinemann Hans Hekland Tone Kvåle Prof. Dr. Dr. med. Andreas Pfützner Renete Kaarvik Jo Oeding Amundstad Ahmad Fazli Barbora Tencer Aslak Fisketjønn Asle Steiestøl Wingsternes Jordan Gardiner Torsten Ernst Nicole Thomé Mandar Mehta Dr. Preeti SHARMA

Today Lifecare conducted an Extraordinary General Meeting where the Boards proposal for a partly underwritten rights issue was approved. All exisiting shareholders in Lifecare as of May 16th, 2024, 4:30 PM CEST will have preferential rights in the issue that will be open for subscribtion May 30th - June 13th. The EGM was conducted as a hybrid meeting where shareholders can participate in person og online. We use the meeting portal Orgbrain for all our board meetings and general meetings. Morten Foros Krohnstad chaired the meeting, while Renete Kaarvik, Asle Steiestøl Wingsternes and Aslak Fisketjønn ensured a technical and practical smooth execution. Schjødt and Carnegie Investment Bank provided great assistance preparing for the EGM Lifecare will publish practical information related to the rights issue in advance of the subscription period starting May 30th. https://lnkd.in/dW7pcxdh Trine Teigland Lutz, Prof. Dr. Heinemann Hans Hekland Tone Kvåle Prof. Dr. Dr. med. Andreas Pfützner Julie Lundekvam Jo Oeding Amundstad Barbora Tencer Ahmad Fazli Jordan Gardiner Nicole Thomé Mandar Mehta Dr. Preeti SHARMA Torsten Ernst Karl Martin Dolvik Stefan Slemdal Audun Bondkall